SEC Form 4 · accession 0001140361-18-024412
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Palle Jr.
Officer — President and CEO · Director · 10% Owner
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2,F3 | $0.87 | May 15, 2018 | A | 100,000 | A | — | May 15, 2028 | Common Stock par value $0.001 | 100,000 | 100,000 | D |
Explanation of responses
- F1The stock option was granted under the 2016 Employee Equity Incentive Plan.
- F2The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE American) of the common stock on the grant date.
- F3The stock option vests in three equal installments of one-third each on the first, second and third anniversary of the date of grant.